Dealing with Renin-Angiotensin Inhibitors, Don’t Mind Serum Creatinine

Volume: 36, Issue: 5, Pages: 427 - 429
Published: Jan 1, 2012
Abstract
tem (RAS) such as angiotensin-converting enzyme inhibitors (ACEi) or angiotensin II receptor blockers (ARBs). A review of 1,102 CKD patients from 12 randomized clinical trials clearly showed that in these cases the initial serum creatinine increase associated with RAS inhibitor-based antihypertensive regimens is also followed by slower disease progression [3] . Note that larger shortterm increases were associated with slower GFR decline in the...
Paper Details
Title
Dealing with Renin-Angiotensin Inhibitors, Don’t Mind Serum Creatinine
Published Date
Jan 1, 2012
Volume
36
Issue
5
Pages
427 - 429
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.